TY  - JOUR
T1  - IS insulin the preferred compound in lowering glucose levels in patients after a myocardial infarction?—reply
AU  - Kosiborod M, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Spertus JA
Y1  - 2009/09/28
N1  - 10.1001/archinternmed.2009.327
JO  - Archives of Internal Medicine
SP  - 1633
EP  - 1638
VL  - 169
IS  - 17
N2  - 

			While not the main objective of our study (which was to evaluate whether normalization of glucose levels is associated with better survival), the impact of insulin therapy on patient outcomes in a setting of AMI is an important and controversial issue. While treatment thresholds and therapeutic goals remain subjects of intense debate, professional societies currently endorse glucose control in patients with AMI and significant hyperglycemia (blood glucose level >180 mg/dL [to convert to millimoles per liter, multiply by 0.0555]),2 and insulin remains the only reliable way to effectively lower glucose levels in hospitalized patients.
		

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2009.327
UR  - http://dx.doi.org/10.1001/archinternmed.2009.327
ER  -